Cabozantinib
Cabozantinib
Cabozantinib (pronounced as ka-bo-zan-ti-nib) is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2. It is used in the treatment of various types of cancer, including renal cell carcinoma and hepatocellular carcinoma.
Etymology
The name "Cabozantinib" is derived from the abbreviation of the chemical name CAlcium BOrate ZANthate TItanium NIBble.
Usage
Cabozantinib is used to treat certain types of cancer (such as kidney cancer, thyroid cancer, and liver cancer). It works by slowing or stopping the growth of cancer cells.
Side Effects
Common side effects of Cabozantinib include fatigue, decreased appetite, diarrhea, nausea, and hand-foot syndrome. More serious side effects may include hypertension, bleeding, blood clots, and perforations in the stomach or intestines.
Related Terms
External links
- Medical encyclopedia article on Cabozantinib
- Wikipedia's article - Cabozantinib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski